Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic skin condition characterized by painful lumps, abscesses, and scarring, typically occurring in areas where skin rubs together, such as the armpits and groin.
Hidradenitis Suppurativa: Sonelokimab Treatment Study
We are testing a new injectable medication, sonelokimab, for adults with moderate to severe hidradenitis suppurativa. The study aims to see if it can improve symptoms compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you currently pregnant or breastfeeding?
- Do you have a history of hidradenitis suppurativa (HS) for at least 6 months?
- Are you currently taking any antibiotics for HS that have not changed in the last 28 days?
- Do you have any known allergies to sonelokimab or its ingredients?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sonelokimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Universitätsklinik für Dermatologie Abteilung für Allgemeine Dermatologie
Vienna, Austria
University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD
Clinic of Skin and Venereal Diseases
Pleven, Bulgaria
ASMC IPSMC Skin And Venereal Diseases
Sofia, Bulgaria
Sponsor: MoonLake Immunotherapeutics AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.